(Q44980276)

English

In vivo 31P NMR spectroscopy shows an increase in glycerophosphorylcholine concentration without alterations in mitochondrial function in the prefrontal cortex of medicated schizophrenic patients at rest

scientific article published in August 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

In vivo 31P NMR spectroscopy shows an increase in glycerophosphorylcholine concentration without alterations in mitochondrial function in the prefrontal cortex of medicated schizophrenic patients at rest (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

0 references

author name string

Yukihiko Shirayama

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Toshio Yano

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Kiyohisa Takahashi

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Seizo Takahashi

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Takashi Ogino

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

language of work or name

0 references

publication date

1 August 2004

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

European Journal of Neuroscience

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

749-756

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Negative symptoms in schizophrenia. Definition and reliability

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

Increased glycerol-3-phosphorylcholine in post-mortem Alzheimer's brain.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

Quantitative proton-decoupled 31P MRS of the schizophrenic brain in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

AIDS dementia complex: brain high-energy phosphate metabolite deficits

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

Anterior cingulate gyrus dysfunction and selective attention deficits in schizophrenia: [15O]H2O PET study during single-trial Stroop task performance.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

Decreased cytochrome-c oxidase activity and lack of age-related accumulation of mitochondrial DNA deletions in the brains of schizophrenics.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

Synaptic plasticity: on the trail of the retrograde messenger

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

Haloperidol improves membrane phospholipid abnormalities in temporal lobes of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

Increased platelet phospholipase A2 activity in schizophrenia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

Further evidence for dementia of the prefrontal type in schizophrenia? A controlled study of teaching the Wisconsin Card Sorting Test

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

P-31 MR spectroscopy of normal human brain and brain tumors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

Region-specific changes in phospholipid metabolism in chronic, medicated schizophrenia: (31)P-MRS study at 4.0 Tesla

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings--part II.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

Quantitation of in vivo phosphorus metabolites in human brain with magnetic resonance spectroscopic imaging (MRSI).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

Elevated PLA2 activity in schizophrenics and other psychiatric patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

Increased platelet membrane lysophosphatidylcholine in schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

Cerebral metabolism in hyper- and hypocarbia: 31P and 1H nuclear magnetic resonance studies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

A 1H-decoupled 31P chemical shift imaging study of medicated schizophrenic patients and healthy controls.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

Correlation of positive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenics.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

Multiple regression analysis of relationship between frontal lobe phosphorus metabolism and clinical symptoms in patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings--part I.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

31Phosphorus magnetic resonance spectroscopy of the dorsolateral prefrontal region in schizophrenics--a study including 50 patients and 36 controls.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

Implications of normal brain development for the pathogenesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

Schizophrenia and the frontal lobe

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

Simultaneous Determination of Intracellular Magnesium and pH from the Three 31P NMR Chemical Shifts of ATP

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

Localized phosphorus 31 magnetic resonance spectroscopy in chronic schizophrenic patients and normal controls.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

Functional magnetic resonance imaging of schizophrenic patients and comparison subjects during word production.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

Selective Relationship Between PrefrontalN-Acetylaspartate Measures and Negative Symptoms in Schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03524.X

21 January 2018

Identifiers

10.1111/J.1460-9568.2004.03524.X

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44980276&oldid=2060375119"